The incidence of breast cancer is higher in women with primary Sjögren’s syndrome than the general population, a study from Taiwan indicates. Diabetes and high levels of anti-SSA autoantibodies were associated with a higher risk of developing breast cancer, according to “…
News
In adults with Sjögren’s syndrome with missing teeth, implant-supported overdentures — which are removable dentures that rest on implants — may improve the ability to chew, potentially leading to better quality of life, a study has found. The study, “Implant supported overdentures in Sjögren’s disease patients: a multicentre…
Autologous serum and platelet-rich eye drops work equally well to relieve dry eyes in people with primary Sjögren’s syndrome, but the latter may be more convenient because they take less time to prepare, a study suggests. The study, “Efficacy and safety of platelet-rich plasma and autologous-serum eye drops…
A Regenstrief Institute research scientist will use a five-year, $4.7 million federal grant on a Sjögren’s syndrome biomarker research project and dental training program aimed at fostering collaboration among healthcare professionals and incorporating into clinical practice research on disorders that affect oral health. Specifically, the grant from the National…
People with Sjögren’s syndrome who’ve had it for fewer than three years or whose disease is more active are at a higher risk of developing lupus, according to a study in Korea. Other factors linked to a higher lupus risk included a low number of white blood cells,…
Injecting the salivary glands with stem cells derived from fatty tissue was shown to ease the symptoms of Sjögren’s syndrome in a small clinical trial. “[Stem cell] therapy can provide relief of oral and eye’s dryness in our trial in a short time and has potential improvement of subjective…
Telitacicept, RemeGen’s experimental under-the-skin injection therapy, significantly reduced disease severity in adults with primary Sjögren’s syndrome (pSS), according to final data from a Phase 2 clinical trial. Results were detailed in the study “Efficacy and safety of telitacicept in primary Sjögren’s syndrome: a randomized,…
Supporters around the world are preparing to use their voice to educate others about Sjögren’s syndrome for World Sjögren’s Day — set aside each July 23 to call attention to the chronic autoimmune disease. Sjögren’s syndrome is believed to occur in about 0.1% to 1% of the general…
Almost one-third of patients with primary Sjögren’s syndrome (pSS) tested negative for the disease’s two most common autoantibodies — anti-SSA and anti-SSB autoantibodies — in a retrospective study conducted in China. Interstitial lung disease (ILD), a group of conditions marked by inflammation and scarring of lung tissue, and poorer…
Dazodalibep, Horizon Therapeutics’ experimental therapy for Sjögren’s syndrome, was found to safely and effectively ease disease activity and symptoms across two divergent groups of people with the chronic autoimmune disorder. These groups included people with Sjögren’s who had generally been excluded from recent clinical trials — patients with…
Recent Posts
- Sjögren’s symptoms extend far beyond dryness, U.S. survey finds
- Study links anti-Ro antibody patterns to disease features in Sjögren’s
- Global trial of telitacicept for Sjögren’s doses first patient ‘within weeks’
- Patients, advocates working this month to raise awareness of Sjögren’s
- Biotech, US university partner on new ways to speed Sjögren’s diagnosis
- New study links alternative splicing patterns to Sjögren’s severity
- Initial data from trial testing CLN-978 in Sjögren’s expected this year
- Sjögren’s disease may increase risk of certain digestive cancers: Korean study
- Sjögren’s patients face ‘invisible’ symptoms, lack of understanding
- Sjögren’s protein score may help measure salivary gland inflammation